APA

Shen X., Laber C. H., Sarkar U., Galazzi F., Johnson K. M., Mahieu N. G., Hillebrand R., Fuchs-Knotts T., Barnes C. L., Baker G. A. & Gates K. S. (20180730). Exploiting the Inherent Photophysical Properties of the Major Tirapazamine Metabolite in the Development of Profluorescent Substrates for Enzymes That Catalyze the Bioreductive Activation of Hypoxia-Selective Anticancer Prodrugs. : The Journal of organic chemistry.

Chicago

Shen Xiulong, Laber Charles H, Sarkar Ujjal, Galazzi Fabio, Johnson Kevin M, Mahieu Nathaniel G, Hillebrand Roman, Fuchs-Knotts Tarra, Barnes Charles L, Baker Gary A and Gates Kent S. 20180730. Exploiting the Inherent Photophysical Properties of the Major Tirapazamine Metabolite in the Development of Profluorescent Substrates for Enzymes That Catalyze the Bioreductive Activation of Hypoxia-Selective Anticancer Prodrugs. : The Journal of organic chemistry.

Harvard

Shen X., Laber C. H., Sarkar U., Galazzi F., Johnson K. M., Mahieu N. G., Hillebrand R., Fuchs-Knotts T., Barnes C. L., Baker G. A. and Gates K. S. (20180730). Exploiting the Inherent Photophysical Properties of the Major Tirapazamine Metabolite in the Development of Profluorescent Substrates for Enzymes That Catalyze the Bioreductive Activation of Hypoxia-Selective Anticancer Prodrugs. : The Journal of organic chemistry.

MLA

Shen Xiulong, Laber Charles H, Sarkar Ujjal, Galazzi Fabio, Johnson Kevin M, Mahieu Nathaniel G, Hillebrand Roman, Fuchs-Knotts Tarra, Barnes Charles L, Baker Gary A and Gates Kent S. Exploiting the Inherent Photophysical Properties of the Major Tirapazamine Metabolite in the Development of Profluorescent Substrates for Enzymes That Catalyze the Bioreductive Activation of Hypoxia-Selective Anticancer Prodrugs. : The Journal of organic chemistry. 20180730.